CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
17.12
0.87%
Market Trading Hours* (UTC) Opens on Wednesday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.19
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Core Laboratories Inc ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 17.27
Open* 16.91
1-Year Change* -24.91%
Day's Range* 16.85 - 17.21
52 wk Range 14.98-27.95
Average Volume (10 days) 481.98K
Average Volume (3 months) 7.36M
Market Cap 734.96M
P/E Ratio 18.06
Shares Outstanding 46.72M
Revenue 509.15M
EPS 0.87
Dividend (Yield %) 0.25429
Beta 2.43
Next Earnings Date Jan 31, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 16, 2024 17.12 0.23 1.36% 16.89 17.27 16.76
Apr 15, 2024 17.27 -0.01 -0.06% 17.28 17.60 17.15
Apr 12, 2024 17.45 -0.33 -1.86% 17.78 18.11 17.12
Apr 11, 2024 17.80 0.20 1.14% 17.60 17.82 17.39
Apr 10, 2024 17.45 0.35 2.05% 17.10 17.58 17.05
Apr 9, 2024 17.52 0.44 2.58% 17.08 17.54 17.08
Apr 8, 2024 17.18 -0.05 -0.29% 17.23 17.46 17.13
Apr 5, 2024 17.22 0.45 2.68% 16.77 17.37 16.77
Apr 4, 2024 16.91 -0.23 -1.34% 17.14 17.54 16.84
Apr 3, 2024 17.27 0.20 1.17% 17.07 17.47 17.07
Apr 2, 2024 17.24 0.21 1.23% 17.03 17.27 16.62
Apr 1, 2024 17.05 0.07 0.41% 16.98 17.08 16.70
Mar 28, 2024 16.94 -0.07 -0.41% 17.01 17.16 16.93
Mar 27, 2024 16.92 0.56 3.42% 16.36 16.98 16.34
Mar 26, 2024 16.44 -0.60 -3.52% 17.04 17.04 16.30
Mar 25, 2024 17.06 0.51 3.08% 16.55 17.09 16.55
Mar 22, 2024 16.56 0.00 0.00% 16.56 16.78 16.44
Mar 21, 2024 16.78 0.33 2.01% 16.45 16.80 16.37
Mar 20, 2024 16.54 0.48 2.99% 16.06 16.73 16.01
Mar 19, 2024 16.26 0.34 2.14% 15.92 16.28 15.88

Core Laboratories Events

Time (UTC) Country Event
Wednesday, April 24, 2024

Time (UTC)

20:00

Country

US

Event

Q1 2024 Core Laboratories Inc Earnings Release
Q1 2024 Core Laboratories Inc Earnings Release

Forecast

-

Previous

-
Thursday, April 25, 2024

Time (UTC)

12:30

Country

US

Event

Q1 2024 Core Laboratories Inc Earnings Call
Q1 2024 Core Laboratories Inc Earnings Call

Forecast

-

Previous

-
Wednesday, May 8, 2024

Time (UTC)

14:00

Country

US

Event

Core Laboratories Inc Annual Shareholders Meeting
Core Laboratories Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 489.735 470.252 487.267 668.21 700.846
Revenue 489.735 470.252 487.267 668.21 700.846
Cost of Revenue, Total 393.655 367.896 374.767 495.579 496.964
Gross Profit 96.08 102.356 112.5 172.631 203.882
Total Operating Expense 448.211 424.99 564.072 571.526 582.224
Selling/General/Admin. Expenses, Total 38.117 44.173 34.033 48.023 62.91
Depreciation / Amortization 17.161 18.516 20.867 22.605 23.087
Interest Expense (Income) - Net Operating 0.229 -0.228 1.16 1.725 2.598
Unusual Expense (Income) 2.264 -1.439 135.268 -1.737 -0.455
Other Operating Expenses, Total -3.215 -3.928 -2.023 5.331 -2.88
Operating Income 41.524 45.262 -76.805 96.684 118.622
Interest Income (Expense), Net Non-Operating -11.57 -9.152 -14.372 -14.69 -13.328
Net Income Before Taxes 29.954 36.11 -91.177 81.994 105.294
Net Income After Taxes 19.658 20.219 -97.073 94.284 79.847
Minority Interest -0.205 -0.492 -0.14 -0.134 -0.263
Net Income Before Extra. Items 19.453 19.727 -97.213 94.15 79.584
Total Extraordinary Items 0 0 -0.424 7.833 -0.058
Net Income 19.453 19.727 -97.637 101.983 79.526
Income Available to Common Excl. Extra. Items 19.453 19.727 -97.213 94.15 79.584
Income Available to Common Incl. Extra. Items 19.453 19.727 -97.637 101.983 79.526
Diluted Net Income 19.453 19.727 -97.637 101.983 79.526
Diluted Weighted Average Shares 46.813 46.69 44.477 44.646 44.474
Diluted EPS Excluding Extraordinary Items 0.41555 0.42251 -2.18569 2.10881 1.78945
Dividends per Share - Common Stock Primary Issue 0.04 0.04 0.28 2.2 2.2
Diluted Normalized EPS 0.44729 0.40525 -0.20885 2.08352 1.78169
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 127.881 128.356 127.571 125.966 120.898
Revenue 127.881 128.356 127.571 125.966 120.898
Cost of Revenue, Total 100.295 101.528 99.816 98.93 97.957
Gross Profit 27.586 26.828 27.755 27.036 22.941
Total Operating Expense 108.975 121.875 111.953 111.321 109.246
Selling/General/Admin. Expenses, Total 5.811 16.331 8.724 10.001 6.847
Depreciation / Amortization 3.937 4.044 4.073 4.171 4.36
Interest Expense (Income) - Net Operating -0.386 -0.144 0.691 -1.303 1.258
Unusual Expense (Income) -0.129 1.752 -0.705 -0.096 -0.111
Other Operating Expenses, Total -0.553 -1.636 -0.646 -0.382 -1.065
Operating Income 18.906 6.481 15.618 14.645 11.652
Interest Income (Expense), Net Non-Operating -3.236 -3.429 -3.081 -3.138 -2.707
Net Income Before Taxes 15.67 3.052 12.537 11.507 8.945
Net Income After Taxes 22.929 2.442 6.69 7.651 7.156
Minority Interest -0.083 -0.069 0.061 -0.127 -0.09
Net Income Before Extra. Items 22.846 2.373 6.751 7.524 7.066
Total Extraordinary Items 0
Net Income 22.846 2.373 6.751 7.524 7.066
Income Available to Common Excl. Extra. Items 22.846 2.373 6.751 7.524 7.066
Income Available to Common Incl. Extra. Items 22.846 2.373 6.751 7.524 7.066
Diluted Net Income 22.846 2.373 6.751 7.524 7.066
Diluted Weighted Average Shares 47.497 47.481 46.379 47.012 47.143
Diluted EPS Excluding Extraordinary Items 0.481 0.04998 0.14556 0.16004 0.14988
Dividends per Share - Common Stock Primary Issue 0.01 0.01 0.01 0.01 0.01
Diluted Normalized EPS 0.47923 0.0795 0.13745 0.15869 0.148
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 211.702 189.055 165.848 221.237 230.977
Cash and Short Term Investments 15.428 17.703 13.806 11.092 13.116
Cash & Equivalents 15.428 17.703 13.806 11.092 13.116
Total Receivables, Net 115.103 106.741 92.867 138.106 143.15
Accounts Receivable - Trade, Net 106.913 96.83 83.192 131.579 129.157
Total Inventory 60.445 45.443 38.151 50.163 45.664
Prepaid Expenses 15.665 14.059 14.797 15.951 15.351
Other Current Assets, Total 5.061 5.109 6.227 5.925 13.696
Total Assets 578.354 580.853 568.579 774.673 648.827
Property/Plant/Equipment, Total - Net 157.407 172.339 181.678 199.203 122.917
Property/Plant/Equipment, Total - Gross 472.144 478.8 475.656 481.39 400.174
Accumulated Depreciation, Total -314.737 -306.461 -293.978 -282.187 -277.257
Goodwill, Net 99.445 99.445 99.445 213.425 219.412
Intangibles, Net 7.483 8.139 8.583 17.45 13.054
Long Term Investments 3.76
Other Long Term Assets, Total 102.317 111.875 113.025 123.358 58.707
Total Current Liabilities 103.135 90.782 89.75 111.594 102.547
Accounts Payable 45.847 29.726 23.028 35.611 41.155
Accrued Expenses 39.952 39.106 44.519 46.896 30.037
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 17.336 21.95 22.203 29.087 31.355
Total Liabilities 394.096 424.404 497.066 596.808 492.068
Total Long Term Debt 172.386 188.636 259.433 305.283 289.77
Long Term Debt 172.386 188.636 259.433 305.283 289.77
Deferred Income Tax 22.877 24.336 20.585 26.284 7.634
Minority Interest 4.696 4.552 4.06 4.275 4.141
Other Liabilities, Total 91.002 116.098 123.238 149.372 87.976
Total Equity 184.258 156.449 71.513 177.865 156.759
Preferred Stock - Non Redeemable, Net 0 0
Common Stock 1.194 1.188 1.148 1.148 1.148
Additional Paid-In Capital 102.254 101.12 41.184 51.872 57.438
Retained Earnings (Accumulated Deficit) 85.949 68.349 50.456 160.539 156.13
Treasury Stock - Common -1.362 -4.075 -14.075 -29.364 -52.501
Unrealized Gain (Loss) 1.331 -4.538 -1.825 -5.64 -6.243
Other Equity, Total -5.108 -5.595 -5.375 -0.69 0.787
Total Liabilities & Shareholders’ Equity 578.354 580.853 568.579 774.673 648.827
Total Common Shares Outstanding 46.6319 46.3494 44.5728 44.4656 44.3168
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 228.544 236.124 227.927 211.702 195.215
Cash and Short Term Investments 16.616 26.204 16.285 15.428 13.732
Cash & Equivalents 16.616 26.204 16.285 15.428 13.732
Total Receivables, Net 104.053 121.373 124.48 115.103 109.493
Accounts Receivable - Trade, Net 104.053 106.816 110.699 106.913 100.195
Total Inventory 75.06 71.658 67.342 60.445 54.795
Prepaid Expenses 11.479 13.197 15.665 11.514
Other Current Assets, Total 32.815 5.41 6.623 5.061 5.681
Total Assets 592.414 601.848 593.617 578.354 570.19
Property/Plant/Equipment, Total - Net 152.6 157.118 159.004 157.407 163.841
Goodwill, Net 99.445 99.445 99.445 99.445
Intangibles, Net 211.27 7.412 7.268 7.483 7.651
Other Long Term Assets, Total 101.749 99.973 102.317 104.038
Total Current Liabilities 84.25 96.194 95.624 103.135 87.359
Accounts Payable 34.097 39.145 38.366 45.847 34.343
Accrued Expenses 9.794 36.179 38.247 39.952 37.323
Notes Payable/Short Term Debt 0 0 0 0
Other Current Liabilities, Total 40.359 20.87 19.011 17.336 15.693
Total Liabilities 362.964 387.092 398.231 394.096 391.654
Total Long Term Debt 177.863 182.583 180.44 172.386 182.677
Long Term Debt 177.863 182.583 180.44 172.386 182.677
Deferred Income Tax 12.126 22.268 22.877 22.719
Minority Interest 4.848 4.765 4.696 4.757
Other Liabilities, Total 100.851 91.341 95.134 91.002 94.142
Total Equity 229.45 214.756 195.386 184.258 178.536
Preferred Stock - Non Redeemable, Net 0
Common Stock 0.467 1.194 1.194 1.188
Additional Paid-In Capital 108.03 111.235 102.254 106.329
Retained Earnings (Accumulated Deficit) 110.234 87.855 85.949 79.662
Treasury Stock - Common -0.436 -1.36 -1.362 -4.143
Unrealized Gain (Loss) 1.511 1.541 1.331 1.095
Other Equity, Total 229.45 -5.05 -5.079 -5.108 -5.595
Total Liabilities & Shareholders’ Equity 592.414 601.848 593.617 578.354 570.19
Total Common Shares Outstanding 46.6804 46.6804 46.634 46.6319 46.3447
Property/Plant/Equipment, Total - Gross 418.091 417.368 419.765 420.352
Accumulated Depreciation, Total -316.429 -315.027 -314.737 -313.1
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 19.658 20.219 -97.073 94.284 79.847
Cash From Operating Activities 24.956 36.579 57.868 89.527 111.827
Cash From Operating Activities 17.161 18.516 20.867 22.605 23.087
Deferred Taxes 0.433 6.012 -12.216 -36.345 1.832
Non-Cash Items 12.723 12.395 140.351 16.69 36.052
Cash Taxes Paid 14.078 9.066 21.325 13.804 31.928
Cash Interest Paid 9.3 10.477 11.669 13.631 11.499
Changes in Working Capital -25.019 -20.563 5.939 -7.707 -28.991
Cash From Investing Activities -3.856 -10.223 7.851 -5.677 -70.639
Capital Expenditures -10.216 -13.539 -11.88 -22.269 -22.931
Other Investing Cash Flow Items, Total 6.36 3.316 19.731 16.592 -47.708
Cash From Financing Activities -23.375 -22.459 -63.005 -85.874 -42.472
Financing Cash Flow Items -2.619 -1.369 -1.766 0.008 -1.77
Total Cash Dividends Paid -1.853 -1.834 -12.446 -97.574 -97.251
Issuance (Retirement) of Stock, Net -3.903 51.744 -2.793 -3.308 -7.451
Issuance (Retirement) of Debt, Net -15 -71 -46 15 64
Net Change in Cash -2.275 3.897 2.714 -2.024 -1.284
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 2.442 19.658 12.968 5.317 -1.839
Cash From Operating Activities -3.169 24.956 11.745 5.895 5.29
Cash From Operating Activities 4.044 17.161 13.088 8.917 4.557
Deferred Taxes 0.936 0.433 -1.807 0.53 1.698
Non-Cash Items 9.242 12.723 13.89 10.043 8.529
Cash Taxes Paid 1.541 14.078 10.475 6.966 2.691
Cash Interest Paid 2.956 9.3 7.101 4.359 2.508
Changes in Working Capital -19.833 -25.019 -26.394 -18.912 -7.655
Cash From Investing Activities -2.038 -3.856 -4.914 -2.357 0.428
Capital Expenditures -2.208 -10.216 -8.195 -5.493 -2.297
Other Investing Cash Flow Items, Total 0.17 6.36 3.281 3.136 2.725
Cash From Financing Activities 6.064 -23.375 -10.802 -5.093 -1.384
Financing Cash Flow Items -1.469 -2.619 -2.102 -0.001 -0.001
Total Cash Dividends Paid -0.466 -1.853 -1.389 -0.926 -0.463
Issuance (Retirement) of Stock, Net -0.001 -3.903 -2.311 -2.166 -1.92
Issuance (Retirement) of Debt, Net 8 -15 -5 -2 1
Net Change in Cash 0.857 -2.275 -3.971 -1.555 4.334

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Core Laboratories Company profile

About Core Laboratories N.V.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Core Laboratories N.V. revenues decreased 3% to $470.3M. Net income before extraordinary items totaled $19.7M vs. loss of $97.2M. Revenues reflect Reservoir Description segment decrease of 12% to $313.6M, United States segment decrease of 7% to $148.2M, Other Countries segment decrease of 2% to $322.1M. Net Income reflects Production Enhancement segment income totaling $15.2M vs. loss of $133.4M.

Equity composition

Common Stock EUR.02 Par 3/11, 200M auth., 49,739,912 issd., less 4,164,536 shs. in Treas. @ $261.4M. Insiders own 1.35%. IPO 9/95,2.8M shs @ $12 by Jefferies. PO 11/97, 300.8M. shs(1.4M by Co.) @ $36 by BTAB. 12/97, 2-for-1 stock split. FY'02-03 fincls. & '03 Qs are restated for discont. ops. 07/10, 2-for-1 stock split.

Industry: Testing Laboratories

6316 Windfern Road
HOUSTON
TEXAS 77040
US

Income Statement

  • Annual
  • Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

People also watch

US100

17,746.70 Price
+0.120% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

63,533.20 Price
+0.710% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.50 Price
+0.870% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Gold

2,391.05 Price
+0.340% 1D Chg, %
Long position overnight fee -0.0192%
Short position overnight fee 0.0109%
Overnight fee time 21:00 (UTC)
Spread 0.40

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading